Client Profile: Optiscan Biomedical

Optiscan Biomedical, www.Farir.com, is successful medical device firm that is developing a continuous glucose monitoring device for hospital use. In October of 2005 they raised $36 million in a Series B funding round to help launch their prototype to their hospital market. After this funding, Optiscan needed a much larger facility to help launch their product line.

Optiscan hired Aegis Realty Partners to assist in the relocation of their headquarters and to research expansion options. Optiscan, who had been located in Alameda, felt a location farther south in Hayward would be helpful in the recruitment of employees facilitate growth needs. Aegis was able to secure a former medical device facility in Hayward that would allow Optiscan to phase their growth into an entire building while paying a consistently lower rental rate.